Outset Medical Beat Q2 Wall Street Projections

Shares of Outset were up after an announcement that the company is selling machines and has beat the Wall Street predictions. The full-year revenue is estimated to be between $97 and $100 million for 2021.

Read the full article » | Posted 09-14-2021

Related Articles

• Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features Posted 07-13-2022
• Baxter Showcases Kidney Care Products Posted 06-10-2022
• DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022
• Outset Tablo Could Boost Use of Home Hemodialysis Posted 05-12-2022